Browse All

Current Filters

CLEAR FILTER x

TITLE

Clusterin as a Candidate CSF Biomarker of Amytrophic Lateral Sclerosis

Author:Kanovsky, Petr   Kaiserova, Michaela   Kurcova, Sandra   Bucilova, Katerina   Konickova, Dorota   Kupcova, Aneta   Mensikova, Katerina   

Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P8.012  

Author Institution:Palacky University Olomouc, Olomouc, Czech Republic  Palacky University Olomouc, Olomouc , Czech Republic  University Hospital Olomouc, Olomouc, Czech Republic  

Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the Open-Label Phase of the PERSIST Study

Author:Yu, Shengyuan   Zhou, Jiying   Zhuang, Junpeng   Liu, Hui   Qian, Chenxi   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.006  

Author Institution:Chinese PLA General Hospital, Beijng, China, People's Republic of  The first Affiliated Hospital of Chongqing Medical University, Chongqing, China, People's Republic of  Eli Lilly and Company, Shanghai, China, People's Republic of  

Clinical Management of Rett Syndrome in the Real World: A Physician Survey

Author:Neul, Jeffrey   May, Damian   Satija, Ambika   Cheng, Wendy   Lema, Neema   Boca, Andra   Lefebvre, Patrick   Piña-Garza, Jesús Eric   

Session Name:P12: General Neurology: Neurogenetics 2  

Topic:General Neurology  

Program Number:P12.002  

Author Institution:Vanderbilt University Medical Center, Nashville, TN  Acadia Pharmaceuticals Inc., San Diego, CA  Analysis Group, Inc., Boston, MA  Analysis Group, Inc., Menlo Park, CA  Analysis Group, Inc., Montréal, QC, Canada  Centennial Children’s Hospital, Nashville, TN  

Impact of treatment over thickness of the retinal layers in patients with demyelinating diseases

Author:Gomez Figueroa, Enrique   Rodríguez-Rivas, Roberto   Rivas, Veronica   Corona Vazquez, Teresita   Flores, Jose de Jesus   

Session Name:P13: MS Clinical Assessments and Outcome Measures  

Topic:MS and Inflammatory Disease  

Program Number:P13.013  

Author Institution:Hospital Civil de Guadalajara. «Fray Antonio Alcalde». , Guadalajara, Mexico  Instituto Nacional de Neurología y Neurocirugía. Manuel Velazco Suárez., CDMX, Mexico  Universidad Nacional Autónoma de México, CDMX, Mexico  

Telomere Length as a biomarker in Multiple Sclerosis

Author:PIEDRABUENA, MARIA   Correale, Jorge   Farez, Mauricio   Fiol, Marcela   Marrodan, Mariano   Ysrraelit, Celica   

Session Name:S9: MS Biomarkers, Immunology, and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:S9.002  

Author Institution:FLENI, CABA, Argentina  FLENI, Buenos Aires, Argentina